A Study to Assess the Safety, Tolerability and Clinical Activity of TD-1211 in Patients With Opioid-Induced Constipation

Clinical trial NCT01333540 · COMPLETED

Trial details

NCT number: NCT01333540
Sponsor: Glycyx Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid-induced Constipation (OIC)

Start date: 2011-05-01
Primary completion: 2012-05-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.